Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esthesioneuroblastoma.

J P Shah, J Feghali

    CA: a Cancer Journal for Clinicians
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Esthesioneuroblastoma, a rare cancer, often presents as locally advanced disease. Combining surgery and radiation therapy, particularly radical resection followed by postoperative radiation, offers improved survival rates for esthesioneuroblastoma patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
    Same author

    Gamete intrafallopian transfer: A preliminary experience.

    The National medical journal of India·2018
    Same author

    SU-E-I-02: Size-Dependent Computed Tomography Histogram Analysis: Towards Breast Tissue Segmentation.

    Medical physics·2017
    Same author

    Ethical issues in non-intervention trials for thyroid cancer.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
    Same author

    Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.

    Oral oncology·2016
    Same author

    The impact of family history on non-medullary thyroid cancer.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
    Same journal

    Serious mental illness and cancer: A call to action for equitable care.

    CA: a cancer journal for clinicians·2026
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Oncology
    • Head and Neck Surgery
    • Cancer Research

    Background:

    • Esthesioneuroblastoma (ENB) is an extremely rare malignant tumor arising from the olfactory epithelium.
    • This retrospective review analyzes clinical data to understand ENB's epidemiology, presentation, and treatment outcomes.
    • Understanding ENB's characteristics is crucial for optimizing patient management and improving survival.

    Purpose of the Study:

    • To review the clinical characteristics and treatment outcomes of esthesioneuroblastoma patients.
    • To identify factors influencing survival in esthesioneuroblastoma.
    • To recommend optimal management strategies for esthesioneuroblastoma.

    Main Methods:

    • Retrospective review of clinical records for 31 patients diagnosed with esthesioneuroblastoma.

    Related Experiment Videos

  • Analysis of patient demographics, disease stage, treatment modalities, recurrence patterns, and survival data.
  • Evaluation of treatment efficacy, focusing on the combination of surgery and radiation therapy.

    • Main Results:

    • A bimodal age distribution was observed in the patient cohort.
    • Esthesioneuroblastoma was noted to be rare among Black patients.
    • Most patients presented with locally advanced disease, but regional/distant metastases were uncommon at diagnosis.
    • Local recurrence was frequent, potentially due to conservative surgery or tumor multicentricity.
    • Cervical lymph node metastasis occurred in less than 10% of patients at diagnosis.
    • Survival rates were significantly better for patients with earlier disease stages.
    • The overall five-year survival rate in this series was 52%.

    Conclusions:

    • Esthesioneuroblastoma management should integrate both surgical intervention and radiation therapy.
    • Radical resection followed by postoperative radiation therapy is identified as the preferred treatment combination.
    • Early-stage diagnosis and aggressive, combined-modality treatment are key to improving esthesioneuroblastoma outcomes.